Dr. Reddy’s joins forces with Gilead Sciences to launch HIV drug Lenacapavir in India and 120 countries
In a historic development for HIV treatment worldwide, Dr. Reddy's Laboratories has announced a new partnership with Gilead Sciences to manufacture and commercialize a revolutionary ... Read More
Zydus Lifesciences gains FDA approval for Darunavir Tablets in HIV-1 treatment
Zydus Lifesciences Limited, a prominent name in the global pharmaceutical industry, has achieved a significant milestone with the United States Food and Drug Administration (FDA) ... Read More
Aurobindo Pharma gains FDA approval for Darunavir Tablets
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Darunavir Tablets, 600 mg and 800 ... Read More
Lupin gains tentative FDA approval for Dolutegravir Tablets generic
Indian pharmaceutical company Lupin announced that the US Food and Drug Administration (FDA) has granted tentative approval for its Abbreviated New Drug Application (ANDA) for ... Read More
Lupin rolls out Darunavir Tablets, generic of Prezista in US
Lupin, an Indian pharmaceutical company, has announced the launch of Darunavir Tablets, available in 600mg and 800mg variants in the US. These tablets serve as ... Read More
Gilead Sciences gets Sunlenca FDA approval for multi-drug resistant HIV
Sunlenca FDA approval : Gilead Sciences has secured the approval of the US Food and Drug Administration (FDA) for Sunlenca (lenacapavir), in combination with other ... Read More
Lupin Limited gets FDA nod for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets
Lupin Limited (Lupin) said it has secured approval for its Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg, from the US Food and Drug ... Read More
ViiV Healthcare’s Cabenuva secures FDA approval for HIV treatment
ViiV Healthcare has received FDA approval for Cabenuva, a long-acting treatment regimen for HIV-1 infection in adult patients. This new therapy is poised to transform ... Read More
Gilead Sciences bags Descovy FDA approval for prevention of HIV infection
Descovy FDA approval : Gilead Sciences’ Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg tablets; F/TAF) has been approved by the US Food and ... Read More
ViiV Healthcare secures Dovato EMA approval for HIV-1 treatment
Dovato EMA approval : The European Commission (EC) has approved ViiV Healthcare’s once-daily, single-pill, two-drug regimen Dovato (dolutegravir/lamivudine) for the treatment of human immunodeficiency virus ... Read More